The boards of directors of Dr. Agarwal Health Care and Dr. Agarwal Eye Hospital have approved the scheme of amalgamation of Dr. Agarwal Eye Hospital with Dr. Agarwal Eye Hospital, creating a single listed entity housing the entirety of Dr. Agarwal’s operations.

NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Motilal Oswal Report

The proposed merger of Dr. Agarwal Eye Hospital Ltd. with Dr. Agarwal Health Care Ltd. would consolidate the businesses of AHCL and AEHL into a single entity.

This merger would drive better operational and financial efficiency, enhancing the value of overall business through unified capital allocation.

With this merger, on pro forma basis, the minority interest related to a 28% stake of public shareholding in Dr. Agarwal Eye Hospital will be eliminated. The total number of equity shares of Dr. Agarwal Healthcare would increase due to the issuance of new shares to Dr. Agarwal Eye Hospital. This transaction would be EPS-accretive for Dr. Agarwal Healthcare by 5-7% for FY27.

Dr. Agarwal Healthcare remains on track to-

  1. expand its pan-India presence,

  2. enhance its hub-spoke model network,

  3. provide superior technology service in eyecare, and

  4. gain market share in the fragmented eye-care industry.

We value Dr. Agarwal Healthcare on an SOTP basis (25x EV/Ebitda for the surgery business, 15x EV/Ebitda for the opticals business, 13x EV/Ebitda for the pharmacy business, adj for a stake in Dr. Agarwal Eye Hospital/Thind hospital) and arrive at a target price of Rs 530. Maintain Buy.

Click on the attachment to read the full report:

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

. Read more on Research Reports by NDTV Profit.The merger will be subject to requisite approvals from shareholders, stock exchanges, SEBI, and the NCLT.  Read MoreResearch Reports, Markets, Business ​NDTV Profit